The Report Guru

According to the new market research report the remote patient monitoring market is projected to reach USD 117.1 billion by 2025 from USD 23.2 billion in 2020, at a CAGR of 38.2% between 2020 and 2025. The rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, benefits of RPM to reduce the burden on medical resources, advancements in telecommunications, growing incidences of chronic diseases, and increasing investments in telehealth and RPM are the major factors driving the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77155492 The prominent players operating in the remote patient monitoring market include BioTelemetry Inc. (US), Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers AG Germany, OMRON Healthcare (Japan), ALTEN Calsoft Labs (France), Preventice Solutio

According to the new market research report Diagnostic Electrocardiograph Market is expected to reach USD 10.3 billion by 2024 from USD 7.5 billion in 2019, at a CAGR of 6.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173 The growth in the diagnostic electrocardiograph market can primarily be attributed to factors such as the increasing incidence of cardiovascular diseases and technological advancements in devices. The major players in the global diagnostic electrocardiograph market are Koninklijke Philips (Netherlands), GE Healthcare (US), and Nihon Kohden Corporation (Japan). These players have adopted various growth strategies such as service & product launches, partnerships & collaborations, and mergers & expansions to increase their presence in the global market. Koninklijke Philips (Netherlands) was one of the major players operating in the diagnostic electrocardiograph market in 2018. The com

According to the new market research report cardiac monitoring market is projected to reach USD 26.8 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 4.0% from 2020 to 2025. The growth of this market is driven by the increasing prevalence of cardiovascular diseases; availability of reimbursement for CM & CRM devices; launch of innovative products by market players; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55 The major players operating in this Cardiac Monitoring Market are Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), ACS Diagnostics (US), MicroPort Scientific Corporation (China), Hill-Rom Holdings (US), Nihon Kohden (Japan), SCHILLER AG (Switzerland),

According to research report Wearable Medical Devices Market size is projected to reach USD 46.6 billion by 2025 from USD 18.4 billion in 2020, at a CAGR of 20.5% from 2020 to 2025. Wearable healthcare devices are autonomous devices that can be attached, worn, or handheld for monitoring and examining the metabolic & physiological changes that occur in the human body. These devices are also used to record data. Wearable healthcare devices monitor and diagnose many diseases such as sleep apnea, skin temperature, blood glucose level, sleep patterns, general health parameters, fitness, and wellness progress among athletes and fitness enthusiasts. These devices are also used in various therapeutic applications such as pain management, rehabilitative services, and respiratory care. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973 The prominent players operating in this market include Medtronic plc (Ireland), OMRON Corporation (Japan), Ko

According to the new market research report Stable Isotope Labeled Compounds Market is projected to grow at a CAGR of 3.0% during the forecast period to reach USD 312 million by 2024 from USD 269 million in 2019. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199 The growth of this market is driven majorly by the increase in research activities in the pharmaceutical and biotechnology sector, the rising prevalence of cancer, and rising proteomics research. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period. Cambridge Isotope Laboratories (CIL) (US), Merck KGaA (Germany), and URENCO (UK) are the key players operating in the stable isotope labeled compounds market. Other prominent players in the market include IsoSciences, LLC (US), Medical Isotopes, Inc. (US), Omicron Biochemicals, Inc. (US), Trace Sciences International (US), Alsachim (France), Taiyo Nip

According to the new market research report Dental Equipment Market is estimated to reach USD 6.2 billion in 2021 and is projected to reach USD 8.9 billion by 2026, at a CAGR of 7.7% during the forecast period. The dental equipment market is estimated to witness significant growth during the forecast period due to the increasing prevalence of oral health disorders, sedentary and changing lifestyles, growing consumer awareness, and rising dental tourism. An increasing number of dental laboratories investing in CAD/CAM technologies will provide abundant opportunities. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=784 The prominent players in the dental equipment industry are DENTSPLY Sirona (US), Planmeca Group (Finland), Envista Holdings (US), Align Technology (US), A-dec Inc. (US), J. MORITA CORP. (Japan), GC Corporation (Japan), Midmark Corporation (US), Straumann Holdings AG (Switzerland), 3M Company (US), BIOLASE, Inc. (US), 3Shape A/S

According to the new market research report dPCR and qPCR market is projected to reach USD 7.6 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 9.0% between 2020 and 2025. Factors such as the rising incidence of target infectious diseases and genetic disorders; technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204 The global dPCR and qPCR market is highly competitive, with many large, medium-sized, and small market players. As of the financial year ended in March 2019, the global dPCR and qPCR market was dominated by Thermo Fisher Scientific (US), Bio-Rad Lab

According to research report the In Vitro Diagnostics Quality Control Market is projected to reach $1,158 million by 2025 from $961 million in 2020, at a CAGR of 3.8% during the forecast period. Key players are focusing on increasing their presence in this growing market through both organic as well as inorganic growth strategies, such as product launches, agreements, partnerships, collaborations, and expansions. Due to the intense competition in this market, various market players are increasingly focusing on expanding their geographic presence in high-growth emerging markets. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 Bio-Rad Laboratories Inc. (US) was the leading player in the IVD quality control market and accounted for the largest share in 2018. The company is a leading provider of clinical diagnostic systems, analytical devices, and instruments. The company has a robust portfolio of quality control products, data managemen